New Edition:
7th Ed. ©2010 Springer Science+Business Media
Authors/Editors: Edge, S.B.; Byrd, D.R.; Compton, C.C.; Fritz, A.G.; Greene, F.L.; Trotti, A.
From the AJCC Cancer Staging Manual prepared by the American Joint Committee on Cancer, the AJCC Cancer Staging Handbook contains the complete text of the Manual conveniently sized to fit in the pocket of a lab coat for complete portability.* Used by physicians and health care professionals world wide, the Seventh Edition of the AJCC Cancer Staging Handbook brings together all the currently available information on staging of cancer at various anatomic sites and incorporates newly acquired knowledge on the etiology and pathology of cancer. As knowledge of cancer biology expands, cancer staging must incorporate these advances.
Organized by disease site into 57 comprehensive chapters, the Seventh Edition features much-anticipated, major revisions to many chapters including breast, colon, prostate, kidney and others. There are new primary site chapters for extrahepatic bile ducts, distal bile duct, cutaneous squamous cell carcinoma, Merkel cell carcinoma and the adrenal gland plus a vastly expanded section on ophthalmologic malignancies.
User friendly enhancements include:
•A revised and expanded presentation of the principles and rules of TNM staging
•A concise summary of changes in the TNM classification and "Staging at a Glance" opening each chapter to provide a snapshot of staging and coding details
•Numerous new line drawings illustrating key sites throughout the text
•Full-color text to highlight elements of TNM, stage groupings and prognostic factors
The Seventh Edition of the AJCC Cancer Staging Handbook remains the essential reference for oncologists, pathologists, surgeons, cancer registrars and medical professionals worldwide to ensure that all those taking care of cancer patients are fully versed in the language of cancer staging.
Supplemental Update:
©2009 by the American College of Physicians
Authors/Editors: Brian Haynes, MD, PhD
ACP Journal Club, published by the American College of Physicians, is the quintessential EBM journal, and is often positioned near the top of the EBM pyramid.
The combination of ACP Journal Club and PIER provides us with the potential to deliver an EBM product that is superior to competitive offerings. ACP Journal Club is published 6 times per year.
Purpose of ACP Journal Club: "ACP Journal Club's general purpose is to select from the biomedical literature articles that report original studies and systematic reviews that warrant immediate attention by physicians attempting to keep pace with important advances in internal medicine. These articles are summarized in value-added abstracts and commented on by clinical experts."
This title updates: Monthly
What's New in January 2010 - Volume 152, Number 1
Therapeutics
- Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation
- Review: High-dose oral vitamin D supplements and active vitamin D prevent falls in older persons
- Review: First-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension
- A lifestyle intervention improved obstructive sleep apnea more than support and education in obese patients with diabetes
- Treatment of mild gestational diabetes did not prevent neonatal complications but reduced fetal overgrowth
- Perioperative fluvastatin reduced cardiac events after noncardiac vascular surgery
- One or two 7.5-μg doses of MF59-adjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in adults within 21 days
- A 15-μg dose of unadjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in healthy adults within 21 days
- Glatiramer acetate delayed conversion to multiple sclerosis in patients with clinically isolated syndrome
- Psyllium increased symptom relief in patients with the irritable bowel syndrome more than bran or placebo
Clinical Prediction Guide
- An updated BODE index and a simplified ADO index predicted 3-year mortality in COPD better than the original BODE index
- A model combining clinical assessment and NT-proBNP level accurately predicted heart failure in ED patients with dyspnea
